FEROCURE-CV is an advanced combination antibiotic designed to provide broad-spectrum antibacterial coverage, including beta-lactamase–producing organisms. It ensures more effective infection control and improved clinical outcomes in moderate to severe bacterial infections.
Formulated under strict quality standards, FEROCURE-CV offers reliable efficacy and better patient response in routine clinical practice.
Clinical advantages for effective infection control and patient outcomes
Broad-spectrum antibacterial action
Effective against beta-lactamase–producing bacteria
Helps overcome antibiotic resistance
Ensures faster recovery from infections
Well tolerated with proven safety profile
Cefixime A third-generation cephalosporin antibiotic Inhibits bacterial cell wall synthesis
Potassium Clavulanate Beta-lactamase inhibitor Enhances the effectiveness of cefixime against resistant bacteria
FEROCURE-CV is indicated for management of bacterial infections.